Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial
about
Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.Current status of gene therapy for brain tumors.Gene therapy for the nervous system: challenges and new strategies.Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo deliveryAn Engineered Endomorphin-2 Gene for Morphine Withdrawal SyndromePreclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelEffectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaGLP-1-mediated gene therapy approaches for diabetes treatment.Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.A novel region in the CaV2.1 α1 subunit C-terminus regulates fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active zone.Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma.
P2860
Q33950709-2541332D-E13D-4848-A870-EB31E4770182Q34318157-C9E17C3A-B44B-4D60-829B-6B81CBA371F6Q35340196-39FAD834-FCA2-4922-BB58-A660869E9868Q35399152-8894B03E-F956-4A24-B8A5-C183F07BEAD2Q35966106-98BBC9B3-787C-4760-A225-E07CE7A4AD53Q37050094-8DB8789F-57FB-43D8-A349-960989213369Q37730116-4C540E96-0FEB-40B5-A336-A15F779400C8Q38199215-6B514F7F-BD78-4C9B-BB90-CB3B6DBAF3A8Q38287249-ADF90FCC-B419-47B9-B16C-4138DCB54190Q38429364-D278E27D-751B-4FB8-8D41-272DAFEE4BF4Q47141309-EE811DED-C38A-45AB-9637-5BA390918611
P2860
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@ast
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@en
type
label
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@ast
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@en
prefLabel
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@ast
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@en
P2093
P2860
P356
P1476
Safety profile of gutless aden ...... glioma phase 1 clinical trial
@en
P2093
A K M Ghulam Muhammad
Alireza Salem
Catherine Farrokhi
Chunyan Liu
Donna Palmer
Kurt M Kroeger
Kyle R Kelson
Liliana Lacayo
Maria G Castro
Mariana Puntel
P2860
P304
P356
10.1089/HGTB.2012.060
P577
2012-08-01T00:00:00Z